Eric F. Wagner, Ph.D.

A registered patent attorney, Eric Wagner's practice includes preparing and prosecuting patent applications, counseling clients regarding patent matters, preparing patentability, validity and infringement opinions, and portfolio management in the biological sciences.  Dr. Wagner concentrates his practice in the areas of biochemistry, molecular and cellular biology, molecular genetics, immunology, biotechnology and pharmaceuticals.

Prior to joining Moore & Van Allen, Dr. Wagner worked as an associate at a major Intellectual Property law firm in Boston, MA, where he concentrated on biotechnology patent prosecution and related areas of practice.  He then worked for Kimberly-Clark Corporation where he helped establish an intellectual asset (IA) management group which was responsible for the internal review, assessment, and management of corporate intellectual assets.  This group was also responsible for the coordination and management of corporate and sector R&D technology and IA programs to ensure sector business plans aligned with the overall corporate strategy.

Mr. Wagner is admitted to practice in the state of North Carolina and before the United States Patent and Trademark Office. 

Of Note

• Thesis research for his Ph.D. in Immunology from Brown University, focused on the study of human B cell growth and development- as well as the biology of AIDS-associated B cell lymphomas and the role of interleukin-10 in human placental immunity
• Co-author of over 8 peer-reviewed journal articles:
  • Hleb, M., Murphy, S., Wagner, E.F., Hanna, N.H., Sharma, N., Park, J., Li, X.C., Strom, T.  Evidence for cyclin D3 as a novel target of rapamycin in human T lymphocytes.  J. Biol. Chem. 2004 Jul.; 279(30): 31948-31955
  • De Silva, F.S., Venturini, D.S., Wagner, E., Shank, P.S., Sharma, S.  CD4-independent infection of human B cells with HIV type-1: detection of unintegrated viral DNA.  AIDS Res. Hum. Retroviruses.  2001 Nov.; 17(17): 1585-1598
  • Wagner, E.F., Hanna, N., Fast, L.D., Kouttab, N., Shank, P.R., Vazquez, A., Sharma, S.  Novel diversity in IL-4-mediated responses in resting human naïve B cells versus germinal center/memory B cells.  J. Immunol. 2000 Nov.; 165(10): 5573-5579
  • Hanna, N., Hanna, I., Hleb, M. Wagner, E., Dougherty, J., Balkundi, D., Padbury, J.  Gestational age-dependent expression of IL-10 and its receptor in human placental tissues and isolated cytotrophoblasts.  J. Immunol. 2000 Jun.; 164(11): 5721-5728
  • Hleb, M., Wagner, E., Sharma, S.  Cyclin D3- a novel target of rapamycin-mediated growth inhibition in human lymphocytes.  The FASEB Journal 12(5): A763, 1998 (Abstract)
  • Wagner, E.F., Hleb, M., Hanna, N., Sharma, S.  A pivotal role of cyclin D3 and cyclin dependent kinase inhibitor p²⁷ in the regulation of IL-2, IL-4, and IL-10-mediated human B cell proliferation.  J. Immunol. 1998 Aug.; 161(3): 1123-1131
  • Ireland, R.C., Iovene, C., Wagner, E.F., McInnis, R., Oblon, D., Alonso, M.A., Paul, S.R.  Use of messenger RNA differential display to indentify interleukin-11-responsive genes in human unbilical cord messenger mononuclear cells:  IL-11 upregulates the expression of the hMAL gene.  J. Interferon Cytokine Res.  1996 Oct.:  16(1):  829-834
  • Ostroy, S.E., Frede, S,M., Wagner, E.F., Gaitazes, C.G., Janle, E.M.  Decreased rhodopsin regeneration in diabetic mouse eyes.  Invest. Opthalmol. Vis. Sci.  1994 Oct.:  35(11):  3905-3909

Professional Affiliations

• Sigma XI Scientific Research Society
• American Intellectual Property Law Association
• American Bar Association
• Wisconsin State Bar